Cargando…
Apelin as a novel drug for treating preeclampsia
Preeclampsia is a pregnancy-specific disorder of new-onset hypertension and proteinuria after 20 weeks' gestation, often resulting in poor outcome. Previous studies demonstrated that apelin is an endogenous active peptide with visodilation and anti-oxidative stress capabilities. The present stu...
Autores principales: | Wang, Chengshu, Liu, Xiaoli, Kong, Desheng, Qin, Xijing, Li, Yanqing, Teng, Xu, Huang, Xianghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729370/ https://www.ncbi.nlm.nih.gov/pubmed/29250138 http://dx.doi.org/10.3892/etm.2017.5304 |
Ejemplares similares
-
Correlation between Apelin and Some Angiogenic Factors in the Pathogenesis of Preeclampsia: Apelin-13 as Novel Drug for Treating Preeclampsia and Its Physiological Effects on Placenta
por: Hamza, Reham Z., et al.
Publicado: (2021) -
Targeting the elabela/apelin-apelin receptor axis as a novel therapeutic approach for hypertension
por: Song, Jiawei, et al.
Publicado: (2022) -
Ameliorative effect of apelin-13 against renal complications in L-NAME-induced preeclampsia in rats
por: Hamza, Reham Z., et al.
Publicado: (2021) -
Apelin and Apelin Receptor in Follicular Granulosa Cells of Buffalo Ovaries: Expression and Regulation of Steroidogenesis
por: Shokrollahi, Borhan, et al.
Publicado: (2022) -
On Methods for the Measurement of the Apelin Receptor Ligand Apelin
por: Janssens, Peter, et al.
Publicado: (2022)